Search

Dr. Heng will be speaking at a health disparity workshop organized by the NCI Center for Cancer Research and the Division of Cancer Epidemiology & Genetics. She will present her group's multidisciplinary research on transgender breast cancer risk and treatment outcomes.

Dr Baker's abstract, " Effect of testosterone therapy on quantitative breast lobular atrophy in transmasculine individuals" has been accepted for a Poster presentation at the Applications of Medical AI Workshop at Medical Image Computing and Computer Assisted Intervention (MICCAI) Meeting, Singapore...

Dr. Heng joins the Program Commitee of the first workshop on Applications of Medical AI (AMAI), taking place as a Satellite Event of MICCAI 2022 on Sep 18 2022 in Singapore. https://sites.google.com/view/amai2022/home#h.nbe1l6goxbom

Dr. Heng was one of the invited international speakers at the National University of Singapore non-codingRNA symposium 2022. The title of her talk was, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." https://medicine.nus.edu.sg/core-facilities/noncoding-rna-ncrna/events-w...

Dr. V. FeinZachary's abstract, " Effect of testosterone therapy on breast density in transmasculine individuals: A pilot study" has been accepted for an electronic presentation at the 2022 SBI/ACR Breast Imaging Symposium. Congratulations! See the presentation here.

Dr Wulf, one of Dr Heng's mentor at BIDMC, has been recognised as a nominee for the 2022 ASCO Women Who Conquer Cancer (WWCC) Mentorship Award. https://www.conquer.org/news/conquer-cancer-announces-2022-wwcc-mentorsh... This is a well-deserved achivement for Dr. Wulf. She is an outstanding female...

Dr. Heng was one of the speakers at the BIDMC Precision RNA Medicine Core Detection Workshop, "Tools for the discovery and validation of clinically important microRNA biomarkers” on Friday, April 29 th at 9:00 AM – 10:30 AM ET. The title of her talk was, " “Plasma miRNAs associated with cisplatin...

Congratulations to Dr Baker. Her abstract, "Comparing the Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays Using Definiens, InForm, and QuPath" has been accepted for Poster presentation at the CAP annual meeting 2022.